Capecitabine for Pancreatic Cancer User Reviews

Brand names: Xeloda

Rating: 3.3

Capecitabine has an average rating of 3.3 out of 10 from a total of 3 reviews for the treatment of pancreatic cancer. 33% of reviewers reported a positive experience, while 67% reported a negative experience.

10		0%
9		0%
8		33%
7		0%
6		0%
5		0%
4		0%
3		0%
2		0%
1		67%

Anonymous
Taken for less than 1 month
September 1, 2020

"The same med was given to my father with pancreatic cancer. His cancer was considered carcinoid tumors and was originally told he would die of old age before the cancer would get him. Unfortunately, when he took this med, his cancer spread like wildfire and lived a month after he was given this drug."

1 / 10

Was this helpful?Yes No

8 Report

joe...
Taken for 5 to 10 years
December 28, 2024

"I have been on Xeloda for 9 years. When I was heavier, I had no side effects. But when I lost weight intentionally, I had hand tightening, it may have been from another drug. My pancreatic cancer has been stable, no growth."

8 / 10

Was this helpful?Yes No

1 Report

Ver...
Taken for 1 to 6 months
May 15, 2020

"My father was given capecitabine medication by his oncologist to slow down the progression of his pancreatic cancer. It did not work. Cancer spread fast."

1 / 10

Was this helpful?Yes No

2 Report

Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.